ID

28935

Descrição

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3); ODM derived from: https://clinicaltrials.gov/show/NCT00642174

Link

https://clinicaltrials.gov/show/NCT00642174

Palavras-chave

Versões (1)
  1. 18/02/2018 18/02/2018 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

18 de fevereiro de 2018

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Diabetes Mellitus NCT00642174

Inglês

Eligibility Diabetes Mellitus NCT00642174

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus and on oral or parenteral hypoglycemic therapy for at least 1 month.
Descrição

Diabetes Mellitus, Non-Insulin-Dependent | ORAL HYPOGLYCEMIC TREATMENT | Hypoglycemic Agents Parenteral

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0747045
UMLS CUI [3,1]
C0020616
UMLS CUI [3,2]
C1518896
history of coronary artery disease with or without other types of vascular disease (such as peripheral vascular disease).
Descrição

Coronary Artery Disease | Vascular Diseases | Vascular Diseases Absent | Peripheral Vascular Diseases | Peripheral Vascular Diseases Absent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1956346
UMLS CUI [2]
C0042373
UMLS CUI [3,1]
C0042373
UMLS CUI [3,2]
C0332197
UMLS CUI [4]
C0085096
UMLS CUI [5,1]
C0085096
UMLS CUI [5,2]
C0332197
taking aspirin 75-325 mg/day for at least 1 week prior to randomization.
Descrição

Aspirin U/day

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C0456683
between the ages of 18-74 years old.
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
if a woman of child bearing age, must not be pregnant and must agree to use reliable method of birth control during the duration of the study.
Descrição

Childbearing Potential Pregnancy Absent | Childbearing Potential Contraceptive methods

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0032961
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
thienopyridine therapy within 30 days or have a defined need for thienopyridine treatment.
Descrição

thienopyridine | Patient need for thienopyridine

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1120149
UMLS CUI [2,1]
C0686904
UMLS CUI [2,2]
C1120149
coronary artery bypass graft (cabg) or percutaneous coronary intervention (pci) with no stent placed within 30 days.
Descrição

Coronary Artery Bypass Surgery | Percutaneous Coronary Intervention | Placement of stent Absent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0010055
UMLS CUI [2]
C1532338
UMLS CUI [3,1]
C0522776
UMLS CUI [3,2]
C0332197
planned coronary revascularization
Descrição

Coronary revascularisation Planned

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0877341
UMLS CUI [1,2]
C1301732
hemoglobin a1c (hba1c) > or equal to 10 mg/dl within the last 3 months.
Descrição

Glucohemoglobin measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0202054
received fibrolytic therapy <24 hours prior to randomization.
Descrição

Fibrinolytic Therapy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0040044
received non-fibrin-specific fibrinolytic therapy <48 hours prior to randomization.
Descrição

Fibrinolytic Therapy | Fibrin Specific Absent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0040044
UMLS CUI [2,1]
C0015982
UMLS CUI [2,2]
C0205369
UMLS CUI [2,3]
C0332197
at risk of bleeding.
Descrição

Bleeding Risk

Tipo de dados

boolean

Alias
UMLS CUI [1]
C3251812
history of ischemic stroke, transient ischemic attack (tia), intercranial neoplasm, arteriovenous malformation, or aneurysm.
Descrição

Ischemic stroke | Transient Ischemic Attack | Neoplasms, Intracranial | Arteriovenous malformation | Aneurysm

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0948008
UMLS CUI [2]
C0007787
UMLS CUI [3]
C1527390
UMLS CUI [4]
C0003857
UMLS CUI [5]
C0002940
body weight <60 kilograms (kg).
Descrição

Body Weight

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0005910
international normalized ratio (inr) >1.5, platelet count <100,000/mm3, or anemia (hemoglobin <10 gm/dl) within 1 week of study entry.
Descrição

International Normalized Ratio | Platelet Count measurement | Anemia | Hemoglobin measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0525032
UMLS CUI [2]
C0032181
UMLS CUI [3]
C0002871
UMLS CUI [4]
C0518015
are receiving or will receive oral anticoagulation or antiplatelet treatment therapy.
Descrição

Anticoagulation Therapy Oral | Antiplatelet therapy

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0003281
UMLS CUI [1,2]
C1527415
UMLS CUI [2]
C1096021
are being treated with daily non-steroidal anti-inflammatory drugs (nsaids).
Descrição

Anti-Inflammatory Agents, Non-Steroidal

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0003211
are pregnant, breast-feeding or plan to become pregnant.
Descrição

Pregnancy | Breast Feeding | Pregnancy, Planned

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
Voltar ao início da página

Similar models

Eligibility Diabetes Mellitus NCT00642174

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | ORAL HYPOGLYCEMIC TREATMENT | Hypoglycemic Agents Parenteral
Item
type 2 diabetes mellitus and on oral or parenteral hypoglycemic therapy for at least 1 month.
boolean
C0011860 (UMLS CUI [1])
C0747045 (UMLS CUI [2])
C0020616 (UMLS CUI [3,1])
C1518896 (UMLS CUI [3,2])
Coronary Artery Disease | Vascular Diseases | Vascular Diseases Absent | Peripheral Vascular Diseases | Peripheral Vascular Diseases Absent
Item
history of coronary artery disease with or without other types of vascular disease (such as peripheral vascular disease).
boolean
C1956346 (UMLS CUI [1])
C0042373 (UMLS CUI [2])
C0042373 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0085096 (UMLS CUI [4])
C0085096 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
Aspirin U/day
Item
taking aspirin 75-325 mg/day for at least 1 week prior to randomization.
boolean
C0004057 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
Age
Item
between the ages of 18-74 years old.
boolean
C0001779 (UMLS CUI [1])
Childbearing Potential Pregnancy Absent | Childbearing Potential Contraceptive methods
Item
if a woman of child bearing age, must not be pregnant and must agree to use reliable method of birth control during the duration of the study.
boolean
C3831118 (UMLS CUI [1,1])
C0032961 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
thienopyridine | Patient need for thienopyridine
Item
thienopyridine therapy within 30 days or have a defined need for thienopyridine treatment.
boolean
C1120149 (UMLS CUI [1])
C0686904 (UMLS CUI [2,1])
C1120149 (UMLS CUI [2,2])
Coronary Artery Bypass Surgery | Percutaneous Coronary Intervention | Placement of stent Absent
Item
coronary artery bypass graft (cabg) or percutaneous coronary intervention (pci) with no stent placed within 30 days.
boolean
C0010055 (UMLS CUI [1])
C1532338 (UMLS CUI [2])
C0522776 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Coronary revascularisation Planned
Item
planned coronary revascularization
boolean
C0877341 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
Glucohemoglobin measurement
Item
hemoglobin a1c (hba1c) > or equal to 10 mg/dl within the last 3 months.
boolean
C0202054 (UMLS CUI [1])
Fibrinolytic Therapy
Item
received fibrolytic therapy <24 hours prior to randomization.
boolean
C0040044 (UMLS CUI [1])
Fibrinolytic Therapy | Fibrin Specific Absent
Item
received non-fibrin-specific fibrinolytic therapy <48 hours prior to randomization.
boolean
C0040044 (UMLS CUI [1])
C0015982 (UMLS CUI [2,1])
C0205369 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Bleeding Risk
Item
at risk of bleeding.
boolean
C3251812 (UMLS CUI [1])
Ischemic stroke | Transient Ischemic Attack | Neoplasms, Intracranial | Arteriovenous malformation | Aneurysm
Item
history of ischemic stroke, transient ischemic attack (tia), intercranial neoplasm, arteriovenous malformation, or aneurysm.
boolean
C0948008 (UMLS CUI [1])
C0007787 (UMLS CUI [2])
C1527390 (UMLS CUI [3])
C0003857 (UMLS CUI [4])
C0002940 (UMLS CUI [5])
Body Weight
Item
body weight <60 kilograms (kg).
boolean
C0005910 (UMLS CUI [1])
International Normalized Ratio | Platelet Count measurement | Anemia | Hemoglobin measurement
Item
international normalized ratio (inr) >1.5, platelet count <100,000/mm3, or anemia (hemoglobin <10 gm/dl) within 1 week of study entry.
boolean
C0525032 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0002871 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
Anticoagulation Therapy Oral | Antiplatelet therapy
Item
are receiving or will receive oral anticoagulation or antiplatelet treatment therapy.
boolean
C0003281 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1096021 (UMLS CUI [2])
Anti-Inflammatory Agents, Non-Steroidal
Item
are being treated with daily non-steroidal anti-inflammatory drugs (nsaids).
boolean
C0003211 (UMLS CUI [1])
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
are pregnant, breast-feeding or plan to become pregnant.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial